• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Sarah Faulkner

Amputees’ brain remember missing limbs even years later

September 14, 2016 By Sarah Faulkner

Researchers from Oxford University demonstrated that amputees’ brains can remember their missing hands, even 30 years later. At Oxford University’s Hand & Brain Lab, the researchers used an ultra-high-power MRI scanner to monitor the brain activity of 2 people who lost their left hands 25 to 30 years ago. The scientists also scanned the brains […]

Filed Under: Prosthetics, Research & Development Tagged With: Oxford University

Credence MedSystems raises $15m for safe-syringe drug delivery

September 13, 2016 By Sarah Faulkner

Credence MedSystems announced today that it raised $15 million in a Series A round to fund continued development and commercialization of its injectable drug-delivery device. The company’s flagship device is the Credence Companion safety syringe, a pre-fillable device sold to drug manufacturers for use with injectable medications. The user injects their medication, gets a cue […]

Filed Under: Drug-Device Combinations, Funding Roundup Tagged With: Credence MedSystems

Ablative Solutions wins FDA nod for Phase II chemical denervation trial

September 13, 2016 By Sarah Faulkner

Ablative Solutions said today that the FDA approved a Phase II trial of its chemical denervation system for hypertension under its investigational new drug application. The trial, called Target-BP I, will evaluate the efficacy of Ablative’s Peregrine infusion ablation system, which uses ethanol to interrupt signals from sympathetic nerves in the renal artery to control […]

Filed Under: Clinical Trials, Drug-Device Combinations, Food & Drug Administration (FDA) Tagged With: Ablative Solutions, Hypertension, Medtronic, stjudemedical

Adhezion Biomedical, Pfizer ink long-term supply deal

September 13, 2016 By Sarah Faulkner

Adhezion Biomedical announced today that it inked a long-term supply deal with Pfizer (NYSE:PFE) for exclusive U.S. distribution rights for Adhezion’s topical skin adhesives. The Wyomissing, Pa.-based medical device company has a product family of 2-octyl cyanoacrylate adhesives designed to hold the edges of skin wounds together, for use after minimally invasive surgery and simple […]

Filed Under: Distribution, Drug-Device Combinations, Surgical, Wound Care Tagged With: Adhezion Biomedical, Pfizer

Wearable generator that harvests heat could power devices

September 13, 2016 By Sarah Faulkner

Researchers at North Carolina State University developed a wearable that can harvest body heat to power devices with at least 20 times the efficiency of other methods, the school reported yesterday. The study, published in Applied Energy, was conducted at the National Science Foundation’s Nanosystems Engineering Research Center for Advanced Self-Powered Systems of Integrated Sensors […]

Filed Under: Research & Development Tagged With: North Carolina State University

ReWalk Robotics founder’s Upnride wheelchair lets you cruise through town standing

September 13, 2016 By Sarah Faulkner

(Reuters) — Israeli technology start-up Upnride Robotics is launching an innovative upright, self-stabilizing wheelchair at a medical conference in Germany next month and hopes to hit the market next year. Before then, Upnride needs to pass 2 clinical trials, 1 with the U.S. Veterans Affairs Dept. in New York, to help it get regulatory approval and ensure health insurance companies […]

Filed Under: Clinical Trials Tagged With: UPnRIDE Robotics

Coapt looks to bring prosthetic electrodes into the 21st century

September 12, 2016 By Sarah Faulkner

When Jodie O’Connell-Ponkos was 16, she lost her right arm in a meat-grinding accident.* She was given a prosthesis, but quickly came to hate it. It was a standard myoelectric system, using a pair of electrodes. The electrodes measured signals from her muscles, which in turn activated sensors telling the prosthetic to move. She found […]

Filed Under: Prosthetics, Research & Development Tagged With: Coapt

Nordisk issues voluntary recall of GlucaGen HypoKits

September 12, 2016 By Sarah Faulkner

Novo Nordisk (NYSE:NVO) issued a voluntary recall of 6 batches of its GlucaGen HypoKits in the U.S., after reports of detached needles in the syringes. The company initiated the recall following 2 customer complaints, 1 from the UK and 1 from Portugal, according to Novo Nordisk. The recall comes just days after the company announced the […]

Filed Under: Diabetes, Diagnostics, Recalls, Regulatory/Compliance Tagged With: Novo Nordisk

Chemists develop 3D bone-scanning technique

September 12, 2016 By Sarah Faulkner

Chemists at Trinity College Dublin created a 3D bone-scanning technique that does not expose patients to radiation. The team attached a luminescent tag to tiny, gold structures called nanoagents. The particles seek out micro-cracks in bones and adhere to the calcium-rich surface. Using magnetic resonance imaging, the luminescent molecules light up and produce a 3D, […]

Filed Under: Imaging, Orthopedics, Research & Development Tagged With: Royal College of Surgeons in Ireland, Trinity College Dublin

Novocure touts long-term analysis of Optune drug-device combo

September 12, 2016 By Sarah Faulkner

Novocure (NSDQ: NVCR) touted a long-term analysis of data from a Phase III pivotal trial of its Optune device in combination with temozolomide for the treatment of newly-formed glioblastomas. Survival data for nearly 700 patients confirmed interim results from the trial, 1st published in December 2015 in the Journal of the American Medical Assn. Patients treated […]

Filed Under: Clinical Trials, Drug-Device Combinations, Radiosurgery/Radiation therapy Tagged With: NovoCure

AstraZeneca, Bespak ink deal for metered-dose inhaler

September 12, 2016 By Sarah Faulkner

AstraZeneca (NYSE:AZN) said last week that it inked a multi-year commercial supply deal with Consort Medical (LON:CSRT) subsidiary Bespak for its pressurized metered-dose inhaler technology. Bespak will supply inhaler valves and actuators for use with AstraZeneca’s inhaled aerosol treatment for chronic obstructive pulmonary disease. AstraZeneca won FDA approval in April for the aerosol, Bevespi Aerosphere […]

Filed Under: Drug-Device Combinations, Research & Development Tagged With: AstraZeneca plc, Consort Medical

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 249
  • Go to page 250
  • Go to page 251
  • Go to page 252
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS